TISSUE-SPECIFIC BASAL EXPRESSION OF SOLUBLE MURINE EPOXIDE HYDROLASE AND EFFECTS OF CLOFIBRATE ON THE MESSENGER-RNA LEVELS IN EXTRAHEPATIC TISSUES AND LIVER
C. Johansson et al., TISSUE-SPECIFIC BASAL EXPRESSION OF SOLUBLE MURINE EPOXIDE HYDROLASE AND EFFECTS OF CLOFIBRATE ON THE MESSENGER-RNA LEVELS IN EXTRAHEPATIC TISSUES AND LIVER, Archives of toxicology, 70(1), 1995, pp. 61-63
The soluble epoxide hydrolase mRNA level in liver was increased eight-
fold upon administration of the hypolipidemic drug and peroxisome prol
iferator clofibrate for 7 days to mice. The soluble epoxide hydrolase
mRNA was back at control levels within 1-2 days after clofibrate withd
rawal. The highest expression was in liver, intestine and kidney. Lowe
r levels were found in heart and muscle and very low levels were found
in testes, lung, brain and spleen. The mRNA levels were increased in
liver, kidney and heart by clofibrate.